tradingkey.logo

Cvrx Announces Initiation Of Benefit-Hf, A Landmark Heart Failure Trial

ReutersJan 22, 2026 11:10 PM

- CVRx Inc CVRX.O:

  • CVRX ANNOUNCES INITIATION OF BENEFIT-HF, A LANDMARK HEART FAILURE TRIAL EVALUATING BAROSTIM IN SIGNIFICANTLY EXPANDED POPULATION

  • CVRX INC - PRIMARY ENDPOINT: ALL-CAUSE MORTALITY AND HEART FAILURE DECOMPENSATION EVENTS

  • CVRX INC - ENROLLMENT IS EXPECTED TO BEGIN IN THE FIRST HALF OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI